AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2013
Nov 19, 2013
35124_dirs_2013-11-19_c2916eff-16d8-48d3-819b-a7ce0b4ef108.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2013-11-19
Reporting Person: Tardugno Michael H (President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-19 | Celsion Corporation Common Stock | P | 2800 | $3.59 | Acquired | 53521 | Direct |
Footnotes
F1: The Officer purchased the shares on the open market.
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18